This topic contains a solution. Click here to go to the answer

Author Question: In comparison to pemoline (Cylert) and methylphenidate (Ritalin), atomoxetine (Strattera) may prove ... (Read 125 times)

anjilletteb

  • Hero Member
  • *****
  • Posts: 569
In comparison to pemoline (Cylert) and methylphenidate (Ritalin), atomoxetine (Strattera) may prove to:
 
  a. be less effective in the treatment of attention-deficit disorder
  b. worsen depression and cause suicidal ideation
  c. have less potential for abuse in susceptible individuals
  d. be more sedating and cause weight gain

Question 2

During a group session, one of the members states, Let's keep this discussion going so that everyone can participate, but let's keep the time each person speaks to about 3 minutes. The leader interprets this member as acting in which role?
 
  A) Group observer
  B) Gatekeeper
  C) Encourager
  D) Energizer



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raili21

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

C
Strattera may prove to have less potential for abuse than Cylert or Ritalin. However, there appears to be an increased risk of suicidal ideations and liver disease for those taking Strattera, as opposed to Cylert or Ritalin.

Answer to Question 2

B




anjilletteb

  • Member
  • Posts: 569
Reply 2 on: Jul 19, 2018
Wow, this really help


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library